Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis

Review: Daily aspirin reduces short-term risk for cancer and cancer mortality

(2013) Andrew K. Diehl   ANNALS OF INTERNAL MEDICINE

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

(2013) Ramón Estruch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Aspirin on Vascular and Nonvascular Outcomes

(2012) Sreenivasa Rao Kondapally Seshasai   ARCHIVES OF INTERNAL MEDICINE

Aspirin and NSAIDs; benefits and harms for the gut

(2012) Prarthana Thiagarajan et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

A framework for organizing and selecting quantitative approaches for benefit-harm assessment

(2012) Milo A Puhan et al.   BMC Medical Research Methodology

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Prognosis following Upper Gastrointestinal Bleeding

(2012) Stephen E. Roberts et al.   PLoS One

Atrial Fibrillation and the Risk of Sudden Cardiac Death

(2012) Lin Y. Chen et al.   JAMA Internal Medicine

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials

(2011) Jeffrey S. Berger et al.   AMERICAN HEART JOURNAL

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET